Point of Care & Rapid Diagnostics Market projected to Reach USD 72.0 billion by 2027
                     Point of Care & Rapid Diagnostics Market
Global Forecast to 2027
Point of Care & Rapid Diagnostics 
Market is expected to reach 
USD 72.0 billion by 2027 
 Growing at a 
CAGR of  10.8% (2022 – 2027)
POINT OF CARE & RAPID DIAGNOSTICS MARKET
MARKET 
CAGR of OPPORTUNITY OVER KEY MARKET PLAYERS BY PRODUCT
2022 – 2027 NEXT 5 YEA7R2 Sbn

CAGR 43.2 Abbott Laboratories (US)bn  GlucoseSiemens Healthineers AG (Germany)
 Quidel Corporation (US) Infectious 
 F. Hoffman-La Roche Ltd. (Switzerland) Disease(HIV, 
 Hepatitis C)Danaher Corporation (US)
2022 2027
 Becton Pregnancy Test
 Dickinson and Company (US)
North America BY END USER
Europe
Asia Pacific
Rest of the World Pharmacy
Hospital
Home
The Global Point of Care & Rapid Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an 
estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. The growth of the global Point of Care 
diagnostics market can be attributed to factors such as increasing prevalence of respiratory diseases (such as 
COVID-19 and influenza) across the globe, and improved access to point-of-care devices through online platforms 
are some of the other key factors likely to drive the long-term growth of the point-of-care diagnostics market.
Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185
Key Players:
Abbott Laboratories (US), Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffman-La Roche Ltd. 
(Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), Chembio Diagnostics (US), EKF 
Diagnostics (UK), Trinity Biotech plc (Ireland), Instrumentation Laboratory (a Werfen Company) (US), Nova 
Biomedical (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Thermo Fisher Scientific (US), and bioMérieux S.A. 
(France)
Rapid Diagnostics Market Dynamics
Driver:  High prevalence of infectious diseases
POC tests can greatly improve the management of infectious diseases, especially in developing countries where 
access to timely medical care is a challenge and the healthcare infrastructure is antiquated and sparse. According 
to UNAIDS, around 20.6 million people were living with HIV in East and Southern Africa in 2018. In 2019, 20,000 
new HIV cases were registered in the Middle East and North Africa (Source: UNAIDS Data 2020). In the Asia Pacific, 
an estimated 5.8 million people were suffering from HIV in 2019, led by India and China. According to UNAIDS, in 
2019, approximately 2.1 million people in India were infected with HIV. The high prevalence of HIV is likely to 
boost the demand for point-of-care diagnostics, further accelerating the treatment of HIV infection.
Opportunity: Emerging markets
Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities 
for players operating in the POC diagnostics market. This is primarily due to the high and growing prevalence of 
infectious and lifestyle diseases in these countries. Globally, China has the highest number of diabetes patients, 
with around 114 million people suffering from diabetes in the country in 2017. Similarly, in emerging countries 
such as Brazil and India, the prevalence of diabetes, CVDs, and HIV/AIDS is very high. In India, heart diseases 
accounted for 28% of all deaths in 2016, or ~2.8 million people; this is projected to reach ~4.8 million by 2020 
(Source: CCDC, India).
Listed below are important statistics related to major infectious diseases in developing countries:
 According to the WHO, India has the highest tuberculosis burden, with an estimated incidence of 2.64 million 
cases in 2020.
 In 2019, around 4.3 million new tuberculosis cases were reported in Southeast Asia, and 632,000 people died 
due to TB infections in this region (Source: WHO).
 According to the National Influenza Policy 2017, around 10,000 deaths and 40,000 hospitalizations are caused 
due to influenza in South Africa each year.
 According to the WHO, 1.2 million people in Southeast Asia suffer from malaria, with India alone accounting for 
~76% of the total alaria cases.
 During 2014–2016, West Africa reported the largest Ebola epidemic in the region; in two and a half years, the 
outbreak resulted in more than 28,600 cases and 11,325 deaths.
 In 2020, an estimated 15,898 people in Brazil were at risk of Zika virus infections, down from over 30,000 cases 
reported a year earlier.
Get Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=106829185
About MarketsandMarkets™ 
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which 
will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide 
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries 
worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the 
"Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new 
opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of 
incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 
MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) 
annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 
companies this year for their revenue planning and help them take their innovations/disruptions early to the 
market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects 
over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market 
sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
View Full Report - https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-
market-106829185.html